Systemic immune‐inflammation biomarkers in psoriasis patients under interleukin 17A ‐inhibitor treatment
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.18895 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von T Gambichler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Interleukin-17, Psoriasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.
ORCID-Profile: T Gambichler
Zitieren
APA
Gambichler, T., Würfel, L., Abu Rached, N., Mansour, R., Bechara, F. G., & Scheel, C. H. (2023). Systemic immune‐inflammation biomarkers in psoriasis patients under interleukin 17A ‐inhibitor treatment. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18895
Vancouver
Gambichler T, Würfel L, Abu Rached N, Mansour R, Bechara FG, Scheel CH. Systemic immune‐inflammation biomarkers in psoriasis patients under interleukin 17A ‐inhibitor treatment. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18895
BibTeX
@article{Gambichler2023,
author = {Gambichler, T and Würfel, L and Abu Rached, N and Mansour, R and Bechara, F G and Scheel, C H},
title = {Systemic immune‐inflammation biomarkers in psoriasis patients under interleukin 17A ‐inhibitor treatment},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.18895}
}
EUVIMED